Tyep 2 diabetess
Conditions
Interventions
Group of short-term intensive insulin therapy:None
Sponsors
The Third Affiliated Hospital Sun Yat-sen University
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: 1.Type 2 diabetes patients hospitalized in our endocrinology department from January 2021 to May 2025; 2.diagnosed with T2DM according to 1999 World Health Organization criteria; 3.received continuous subcutaneous insulin infusion using an insulin pump about one week; 4.underwent comprehensive evaluation of ß-cell function before and after insulin treatment;
Exclusion criteria
Exclusion criteria: 1. type 1 diabetes; 2. secondary diabetes; 3. the presence of positive glutamic acid decarboxylase antibody; 4. severe acute diabetic complications; 5. severe infectious diseases; 6. using drugs that affect glucose metabolism, such as glucocorticoids, etc. 7. Pregnant or lactating females; 8. severe hepatic and renal disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting blood glucose;Postprandial blood glucose;HOMA-ß;Disposition index;Early-phase insulin secretion index;Insulin secretion sensitivity index;HOMA-IR; | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood glucose target range time;Blood glucose variability;Mean blood glucose ;Mean blood glucose fluctuations;Hypoglycemia occurs;Insulin dose; | — |
Countries
China
Contacts
Public ContactLongyi Zeng
The Third Affiliated Hospital Sun Yat-sen University
Outcome results
None listed